بررسی تشکیل بیوفیلم در اشریشیا کلی ایزوله شده از نمونه های کلینیکی در شهرستان زاهدان

1. Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J infec Dis. 1987;155(3):377-89. 2. Agarwal J, Srivastava S, Singh M. Pathogenomics of uropathogenic Escherichia coli. Indian j med microbiol. 2012;30(2):141. 3. Mandal J, Acharya NS, Buddhapriya D, Parija SC. Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res. 2012;136(5):842. 4. Oliveira F, Paludo K, Arend L, Farah S, Pedrosa F, Souza E, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res. 2011;10(4):4114-25. 5. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J clin microbiol. 2008;46(2):480-7. 6. Ciesielczuk H, Hornsey M, Choi V, Woodford N, Wareham D. Development and evaluation of a multiplex PCR for eight plasmid-mediated quinolone-resistance determinants. J med microbiol. 2013;62(12):1823-7. 7. Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, et al. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat chembiol. 2009;5(12):913-9. 8. Yang L, Barken KB, Skindersoe ME, Christensen AB, Givskov M, Tolker-Nielsen T. Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiol. 2007;153(5):1318-28. 9. Olson AB, Silverman M, Boyd DA, McGeer A, Willey BM, Pong-Porter V, et al. Identification of a progenitor of the CTX-M-9 group of extended-spectrum β-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob agents chemother. 2005;49(5):2112-5. 10. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type β-lactamases. Antimicrob agents chemother. 2003;47(11):3554-60. 11. Ghasemi Y, Archin T, Kargar M, Mohkam M. A simple multiplex PCR for assessing prevalence of extended-spectrum β-lactamases producing Klebsiella pneumoniae in Intensive Care Units of a referral hospital in Shiraz, Iran. Asian Pac j trop med. 2013;6(9):703-8. 12. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol. 2008;46(2):707-12. 13. Kazemian H, Heidari H, Ghanavati R, Mohebi R, Ghafourian S, Shavalipour A, et al. Characterization of Antimicrobial Resistance Pattern and Molecular Analysis among Extended Spectrum β-Lactamase-Producing Escherichia coli. Pharm Sci. 2016;22(4):279-84. 14. Shahcheraghi F, Nikbin V-S, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009;15(1):37-9. 15. Yazd M, Nazemi A, Mir inargasi M, Khataminejad MR, Sharifi S, Babai kochkaksaraei M. Prevalence of SHV/CTX-M/TEM (ESBL) Beta-lactamase Resistance Genes in Escherichia Coli Isolated from Urinary Tract Infections in Tehran, Iran. Med Lab J. 2010;4(1):0-. 16. Valadbeigi T and Chalabzardi M. Evaluation Frequency of TEM, VEB and Per Gens Extended Spectrum Beta Lactamase Producing of Escherichia coli Strains Isolated from Urinary Tract Infections in Ilam City. J Ilam Univ Med Sci.2016; 24(1): 55-63. 17. Koshesh M, Mansouri S, Hashemizadeh Z, Kalantar-Neyestanaki D. Identification of extended-spectrum β-lactamase genes and ampc-β-lactamase in clinical isolates of escherichia coli recovered from patients with urinary tract infections in Kerman, Iran. Arch Ped Infect Dis. 2016; 5(2): e37968 18. Ghorbani-Dalini S, Kargar M, Doosti A, Abbasi P, Sarshar M. Molecular Epidemiology of ESBL Genes and Multi-Drug Resistance in Diarrheagenic Escherichia coli strains Isolated from Adults in Iran. Iran J pharm Res. 2015; 14(4): 1257–1262. 19. Hosseini-Mazinani SM, Eftekhar F, Milani M, Ghandili S. Characterization of β-Lactamases from Urinary Isolates of Escherichia coli in Tehran. Iran Biomed J. 2007;11(2):95-9. 20. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob agents chemother. 2008;52(8):2818-24. 21. Karimian M, Rostamzad A, Shoaei P. Extended spectrum β-lactamase-producing strains of Escherichia coli in hospitalized children in Isfahan, Iran. Avicenna J Clin Microbiol Infect. 2015; 2(3): e27096. 22. Emamghoreishi F and Kohanteb J. Resistance patterns of Escherichia coli causing urinary tract infection. J Jahrom Univ Med Sci. 2007; 5(1): 1-9. 23. Khorramian B, maneini M, Bolourchi M, Eslampour MA, Niasari-Naslaji A, Aligholo M, et al. Evaluation of the biofilm-forming ability of Staphylococcus aureus isolates from bovine mastitis in Iran. Iran J Comp Biopathol. 2010; 6(4):109-114. 24. May T, Ito A, Okabe S. Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes. Antimicrob agents chemother. 2009;53(11):4628-39.